Joohi Jimenez-Shahed, M.D.

Click on the Expand plus sign sign for the listing of news and events by year. Then click on the link for details or press release.

<2021

Collapse All | Expand All

 

The evolution of valbenazine in treating tardive dyskinesia Nov. 20, 2018
With a recent FDA approval as the first ever therapy for TD, as well as the first ongoing phase 4 clinical trial, valbenazine use is under close watch by clinicians and specialists.
Jimenez-Shahed will lead interactive webcast session about deep brain stimulation for Parkinson's disease Aug. 7, 2017
Deep Brain Stimulation (DBS) is a well-established treatment option for movement disorders when symptoms no longer respond well enough to medications.
Treating Tardive Dyskinesia Without Disrupting Psychiatric Treatment May 30, 2017
Joohi Jimenez-Shahed, MD, discusses her research on the use of deutetrabenazine for the treatment of tardive dyskinesia in patients taking concomitant antipsychotics or neuroleptics.
2017 BCM Faculty Award Winners May 18, 2017
Neurology faculty members recognized at 2017 omnibus awards ceremony encompassing the Norton Rose Fulbright Faculty Excellence Award for Teaching and Evaluation, Early Career Faculty Award for Excellence in Patient Care, Star Award for Excellence in Patient Care, and Graduating Class Outstanding Faculty Award.
Deep-brain stimulation proves helpful for high school coach suffering from Tourrette Syndrome March 14, 2017
There are hundreds of thousands of people who suffer from a disorder called Tourrette Syndrome.
Texas Tourette Symposium — What Makes Them Tic? Jan. 18, 2017
Jimenez-Shahed and Strutt co-direct an educational program that reviews the latest diagnostic and treatment options for Tourette syndrome (TS) and associated co-morbidities, updates research into TS genetics and pathophysiology, and provides information about helping individuals with TS and their families navigate the educational system.
Cullen College graduate student targets areas for brain surgery, wins junior scientist award Dec. 16, 2016
Ilknur Telkes, a fourth-year biomedical Ph.D. student in the Cullen College of Engineering, spends a good bit of her time in the operating room at Baylor College of Medicine.
Directional deep brain stimulation for movement disorders now being used Oct. 7, 2016
Baylor College of Medicine doctors are now using a recently FDA-approved, directional deep brain stimulation system with current steering capabilities to treat movement disorders like Parkinson's disease.
The 10th Annual Johns Hopkins Dystonia & Spasticity Practicum and Update Sept. 14, 2016
Jankovic and Jimenez-Shahed are invited faculty to the interactive CME activity.
Jimenez-Shahed will lead informational session about deep brain stimulation for Parkinson's disease July 15, 2016
Deep Brain Stimulation (DBS) is a well-established treatment option for movement disorders when symptoms no longer respond well enough to medications.
Baylor recognizes excellence among clinicians June 16, 2016
Jimenez-Shahed and Kass were among a group of Baylor College of Medicine faculty members recognized for excellence in patient care at the Master Clinician and Rising Star Clinician Awards ceremony.
Woman battling Parkinson's disease to try out for 'American Ninja Warrior' May 29, 2016
Jimenez-Shahed interviewed by Click2Houston about the benefits of exercise in Parkinson's disease.
Houston Neurological Society sponsors a deep brain stimulation talk March 3, 2016
Dr. Joohi Jimenez-Shahed invited to speak about deep brain stimulation for Parkinson's.
Jimenez-Shahed will lead informational session about deep brain stimulation for Parkinson's disease March 3, 2016
Deep Brain Stimulation (DBS) is a well-established treatment option for movement disorders when symptoms no longer respond well enough to medications.
Jimenez-Shahed will lead informational session about deep brain stimulation for Parkinson's disease Jan. 21, 2016
Deep Brain Stimulation (DBS) is a well-established treatment option for movement disorders when symptoms no longer respond well enough to medications.
Health Watch segment focusing on the cause of Robin Williams' death Nov. 5, 2015
Jimenez-Shahed interviewed by Fox 26 News about Robin Williams and Lewy Body Dementia.
Jimenez-Shahed will lead informational session about deep brain stimulation for Parkinson's disease Oct. 8, 2015
Deep Brain Stimulation (DBS) for Parkinson's disease (PD) is a well-established treatment option when complications of PD treatment become problematic.
Newly Diagnosed Education Program for Parkinson's disease Oct. 8, 2015
Houston Area Parkinson Society offers a quarterly educational program developed specifically for those who have been recently diagnosed with Parkinson's disease.
2014 Annual Report — Parkinson's Disease Center and Movement Disorders Clinic Nov. 1, 2014
November 19, 2014, has been designated as National Philanthropy Day. I would like to celebrate this special day by thanking you for your generous support of our Parkinson's Disease Center and Movement Disorders Clinic (PDCMDC).
2013 Annual Report — Parkinson's Disease Center and Movement Disorders Clinic Oct. 1, 2013
Each year I look forward to preparing this brief report of our clinical, research and educational activities because it gives me an opportunity to highlight some of the accomplishments of the Parkinson's Disease Center and Movement Disorders Clinic at Baylor College of Medicine during the past year and to express my gratitude to my patients, friends and colleagues for their continued support.
2012 Annual Report — Parkinson's Disease Center and Movement Disorders Clinic Oct. 1, 2012
It is my pleasure to briefly summarize the activities of the Parkinson's Disease Center and Movement Disorders Clinic (PDCMDC) over the past year. When I founded the PDCMDC over 35 years ago I could only dream about the international acclaim that it now receives for its accomplishments in clinical care, research and education.
2011 Annual Report — Parkinson's Disease Center and Movement Disorders Clinic Oct. 1, 2011
The primary goal of this annual report is to provide a brief overview of the various activities at the Parkinson's Disease Center and Movement Disorders Clinic (PDCMDC). Consistent with our mission, the PDCMDC has continued to be engaged in a large number of clinical, research, educational and other academic activities.
Botulinum Toxin Workshop Dec. 11, 2010
BCM Neurology faculty help organized the 4th annual Johns Hopkins Dystonia and Spasticity Practicum at the Marriott West Loop, Houston.
2010 Annual Report — Parkinson's Disease Center and Movement Disorders Clinic Oct. 1, 2010
Each year I try to provide a brief overview of the various activities at the Parkinson's Disease Center and Movement Disorders Clinic (PDCMDC). Since my last annual report, the PDCMDC has been engaged in a large number of clinical, research, educational and other academic activities consistent with our missions.
Parkinson's study investigates benefits of creatine Aug. 15, 2007
Baylor College of Medicine is one of 52 sites across the United States and Canada testing the ability of the investigational drug creatine to slow the clinical decline associated with Parkinson's disease.
HD Symposium July 15, 2007